QT interval prolongation in patients on methadone with concomitant drugs [1]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 4, 2004, Pages 446-448

  Piguet, Valerie ^a   Desmeules, Jules ^a   Ehret, Georg ^a   Stoller, Rudolf ^b   Dayer, Pierre ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b Intercantonal Off Contr M   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATENOLOL; BROMAZEPAM; CEFTRIAXONE; CHLORPROTHIXENE; CITALOPRAM; CLARITHROMYCIN; CLORAZEPATE; COCAINE; COTRIMOXAZOLE; EFAVIRENZ; FLUCONAZOLE; FLUNITRAZEPAM; FLURAZEPAM; FUROSEMIDE; INDINAVIR; LAMIVUDINE; LOPINAVIR; LORMETAZEPAM; MAGNESIUM; METHADONE; MIANSERIN; NIFEDIPINE; OLANZAPINE; OXAZEPAM; RITONAVIR; SERTRALINE; UNINDEXED DRUG; VALPROIC ACID; ZIDOVUDINE;

ADULT; CLINICAL ARTICLE; DOSE RESPONSE; DRUG METABOLISM; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LETTER; MALE; PRIORITY JOURNAL; QT PROLONGATION; TORSADE DES POINTES;

ADULT; FEMALE; HUMANS; LONG QT SYNDROME; MALE; METHADONE;

EID: 3242737519     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000132347.81455.57     Document Type: Letter

References (14)

1. Roden DM. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc Res. 2001;50:224-231.
2. De Ponti F, Poluzzi E, Montanaro N. Organising evidence on QT prolongation and occurrence of torsades de pointes with non-antiarrhythmic drugs: a call for consensus. Eur J Clin Pharmacol. 2001;57:185-209.
3. Ferreira S, Crumb JR, Carlton CG, et al. Effects of cocaine and its major metabolites on the HERG-encoded potassium channel. J Pharmacol Exp Ther. 2001;299:220-226.
4. Castillo R, Pedalino RP, El-Sherif N, et al. Efavirenz-associated QT prolongation and torsade de pointes arrhythmia. Ann Pharmacother. 2002;36:1006-1008.
5. Woosley RL. Drugs that prolong the QT interval and/or induce torsades de pointes. Available at: http://www.qtdrugs.org. Accessed June 29, 2003.
6. Kang J, Chen XL, Wang H, et al. Interactions of the narcotic 1-alpha-acetylmethadol with human cardiac K(+) channels. Eur J Pharmacol. 2003;458:25-29.
7. Ulens C, Daenens P, Tytgat J. Norpropoxyphene-induced cardiotoxicity is associated with changes in ion-selectivity and gating of HERG currents. Cardiovasc Res. 1999;44:568-578.
8. Vormfelde SV, Poser W. Death attributed to methadone. Pharmacopsychiatry. 2001;34:217-222.
9. Drummer OH, Syrjanen M, Opeskin K, et al. Deaths of heroin addicts starting on a methadone maintenance programme. Lancet. 1990;335:424.
10. C. Kornick, M. Kilborn, J. Santiago-Palma, et al. QTc interval prolongation with intravenous methadone [abstract]. IASP (San Diego). 2002:58.
11. Krantz MJ, Lewkowiez L, Hays H, et al. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med. 2002;137:501-504.
12. O'Leary ME. Inhibition of human ethera-go-go potassium channels by cocaine. Mol Pharmacol. 2001;59:269-277.
13. O'Leary ME. Inhibition of HERG potassium channels by cocaethylene: a metabolite of cocaine and ethanol. Cardiovasc Res. 2002;53:59-67.
14. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-370.